• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Sterling to receive TFT arrays from OIS

Article

Sterling Diagnostic Imaging has announced that a supply of thin-film transistor (TFT) arrays for its iiRad with DirectRay digital x-ray systems has been assured into the second quarter of 1999. The Greenville, SC-based company reached a settlement with

Sterling Diagnostic Imaging has announced that a supply of thin-film transistor (TFT) arrays for its iiRad with DirectRay digital x-ray systems has been assured into the second quarter of 1999. The Greenville, SC-based company reached a settlement with OIS (Optical Imaging Systems) that will enable Sterling to gain access to all the TFT arrays at OIS, which recently announced it had shut its doors when its primary investor withdrew funding (SCAN 10/14/98). Sterling will also receive work-in-progress arrays from OIS, according to Sterling.

Meanwhile, the company is having encouraging discussions with several alternative TFT suppliers that could result in resumed production of TFT panels for Sterling by mid-1999, said Ernest Waaser, COO. This would result in minimal impact on supply of iiRad with DirectRay systems, he said.

Related Videos
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Nina Kottler, MD, MS
The Executive Order on AI: Promising Development for Radiology or ‘HIPAA for AI’?
Related Content
© 2024 MJH Life Sciences

All rights reserved.